Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1858-2022Class II

The BioZorb LP Marker is an implantable radiopaque marker used to facilitate visualization of a soft tissue...

Hologic, Inc. / initiated 2022-08-09 / Open, Classified / root cause: labeling and UDI

Hologic, Inc began a recall of The BioZorb LP Marker is an implantable radiopaque marker used to facilitate visualization of a soft tissue site. The BioZorb LP Marker is comprised of a... on . FDA classified it as Class II and gives the reason as "Hologic BioZorb LP Marker, (Product number F0221), lot number 22A0RL, contained removable labels with an expiration date that indicated the product had already expired. The expiration date on the removable label is...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1858-2022
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Hologic, Inc.
Product
The BioZorb LP Marker is an implantable radiopaque marker used to facilitate visualization of a soft tissue site. The BioZorb LP Marker is comprised of a bioabsorbable PLA (polylactic acid) component which resorbs completely in 1 year or more and a permanent component (titanium). The BioZorb LP Marker is provided sterile for single use and is implantable.
Product code
NEU Marker, Radiographic, Implantable
Reason for recall
Hologic BioZorb LP Marker, (Product number F0221), lot number 22A0RL, contained removable labels with an expiration date that indicated the product had already expired. The expiration date on the removable label is actually manufacturing date, and it's different from the one on the shelf box label, which is the correct expiration date.
Root cause tag
labeling and UDI
FDA root cause
Incorrect or no expiration date
Action
On August 9, 2022, the recalling firm sent out recall letters with subject line "RE: Incorrect expiration date on BioZorb bioabsorbable marker removable label". Customers were instructed to return any unused product from the affected lot to Hologic. Please contact [email protected] with the number of unused units from Lot#22A20RL that you have. You will be provided a pre paid label to facilitate return. You will also be issued a credit on your account for the returned product. If you wish to reorder product, please place a new order via your preferred procurement method. If material has already been implanted from the affected lot and the patient chart requires updating, Hologic included corrected labels with the recall letter for that purpose.
Quantity in commerce
233
Distribution
US Nationwide distribution including in the states of FL, IL, MD, NJ, AZ, TX, WA, VA, OK, NC, NH, GA, CA, CT, OH, CO, MI, MO, KS, TN, ID, MS, MT, AL, OR, IA, PA, MA.
Product codes and lots
UDI-DI: 15420045514027 Lot 22A0RL Correct Expiration Date is July 8, 2024, but incorrect labels state expiration date of January 20, 2022.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1858-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1858-2022Class IIOngoingVoluntary: Firm initiated